Partner Content Partner Content GSK explores Oral Lipid Based Formulations & Taste Maski... GSK explores Oral Lipid Based Formulations
Partner Content Partner Content Agenda released for SMi Group’s Controlled Release Delivery ... Agenda released for Controlled Release Delivery 2018
Oncology A cancer treatment modality that prioritises QoL, with Ben Z... Immuneering's Ben Zeskind explains how, by focusing on quality of life as well as quantity, they've created a drug for pancreatic cancer.
Sales & Marketing Sponsored How to meet your physicians where they are online A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.
